Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the fourth leading cause of cancer-related death worldwide. Sorafenib is currently acknowledged as a standard therapy for advanced HCC. However, acquired resistance substantially limits the clinical efficacy of sorafe...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Danyang, Yao, Yingcheng, Rao, Yuhan, Huang, Xinyu, Wei, Li, You, Zhimei, Zheng, Guo, Hou, Xiaoli, Su, Yu, Varghese, Zac, Moorhead, John F., Chen, Yaxi, Ruan, Xiong Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966370/
https://www.ncbi.nlm.nih.gov/pubmed/35354475
http://dx.doi.org/10.1186/s13046-022-02306-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966370/
https://www.ncbi.nlm.nih.gov/pubmed/35354475
http://dx.doi.org/10.1186/s13046-022-02306-4

Ejemplares similares